• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs will be updated March 1, 2025:

Effective April 1, 2025:

  • GLP-1 Agonists
  • Insulin Combination Agents
  • Insulin Pump
  • Leqembi
  • Long Acting Insulin
  • Piasky
  • Primary Biliary Cholangitis
  • Pseudobulbar Affect
  • Soliris Ultomiris
  • VMAT2 Inhibitors
  • Weight Management

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page.

If you have any questions please contact your BCBSKS provider representative.